Association of NSAID UseWith Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy AfterMyocardial Infarction

@inproceedings{Olsen2015AssociationON,
  title={Association of NSAID UseWith Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy AfterMyocardial Infarction},
  author={Anne-Marie Schjerning Olsen and Gunnar Hilmar Gislason and Patricia McGettigan and Emil Loldrup Fosb\ol and Rikke Terp S\orensen and Morten Hansen and Lars Valeur K\ober and Christian Torp-Pedersen and Morten Lamberts},
  year={2015}
}
RESULTS We included 61 971 patients (mean age, 67.7 [SD, 13.6] years; 63% men); of these, 34% filled at least 1 NSAID prescription. The number of deaths during a median follow-up of 3.5 years was 18 105 (29.2%). A total of 5288 bleeding events (8.5%) and 18 568 cardiovascular events (30.0%) occurred. The crude incidence rates of bleeding (events per 100 person-years) were 4.2 (95% CI, 3.8-4.6) with concomitant NSAID treatment and 2.2 (95% CI, 2.1-2.3) without NSAID treatment, whereas the rates… CONTINUE READING
0 Citations
38 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 38 references

the Same Cardiovascular Precautions for Diclofenac as for Selective COX-2 Inhibitors

  • PRAC Recommend
  • European Medicines Agency website. http://www.ema…
  • 2015

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation : a systematic review andmeta - analysis of the literature

  • JW Eikelboom, L Wallentin, SJ Connolly
  • Circulation
  • 2012

Similar Papers

Loading similar papers…